This information collection is intended to support research conducted by the Food and Drug Administration (FDA or we). Understanding patients, consumers, and health care professionals' perceptions and behaviors plays an important role in improving FDA's regulatory decisionmaking processes and communications impacting various stakeholders. To better understand patients, consumers, and health care professionals' perceptions and behaviors regarding various issues and patient reported outcomes associated with the safety and administration of drug products overseen by the agency, FDA is requesting approval of this generic information collection request for the purpose of conducting studies in these areas.
The latest form for Data To Support Social and Behavioral Research as Used by the Food and Drug Administration expires 2022-12-31 and can be found here.
Document Name |
---|
Justification for No Material/Nonsubstantive Change |
Supporting Statement B |
Supplementary Document |
Supporting Statement A |
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2023-11-03 | |
Approved without change |
Extension without change of a currently approved collection | 2022-12-28 | |
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2022-05-20 | |
Approved with change |
Reinstatement with change of a previously approved collection | 2019-11-13 | |
Approved without change |
New collection (Request for a new OMB Control Number) | 2017-09-01 |
Federal Enterprise Architecture: Health - Health Care Services